T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.57% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.16% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRFT
1476
DELISTED
Perficient Inc
PRFT
| $4.56M | ﹤0.01% |
220,500
-51,600
| -19% | -$1M |
|
1477
Markel Group
MKL
$22.8B
| $4.54M | ﹤0.01% |
5,907
+385
| +7% | +$278K |
|
1478
Virtus Investment Partners
VRTS
$1.13B
| $4.54M | ﹤0.01% |
34,724
-3,300
| -9% | -$466K |
|
1479
Myriad Genetics
MYGN
$296M
| $4.52M | ﹤0.01% |
127,600
| – | – |
|
|
SAGE
1480
DELISTED
Sage Therapeutics
SAGE
| $4.51M | ﹤0.01% |
+89,878
| New | +$3.86M |
|
|
TRW
1481
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $4.5M | ﹤0.01% |
42,913
-21,587
| -33% | -$2.24M |
|
1482
Children's Place
PLCE
$53.8M
| $4.48M | ﹤0.01% |
69,850
-5,800
| -8% | -$349K |
|
1483
EPAM Systems
EPAM
$5.21B
| $4.46M | ﹤0.01% |
+72,800
| New | +$3.95M |
|
|
FL
1484
DELISTED
Foot Locker
FL
| $4.44M | ﹤0.01% |
70,532
-1,006
| -1% | -$57K |
|
|
ZOES
1485
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $4.36M | ﹤0.01% |
131,100
| – | – |
|
1486
Shake Shack
SHAK
$3.04B
| $4.35M | ﹤0.01% |
+86,890
| New | +$3.9M |
|
1487
Oil States International
OIS
$544M
| $4.29M | ﹤0.01% |
107,930
-5,400
| -5% | -$228K |
|
|
DRE
1488
DELISTED
Duke Realty Corp.
DRE
| $4.2M | ﹤0.01% |
193,061
+2,000
| +1% | +$43K |
|
1489
Crawford & Co Class A
CRD.A
$629M
| $4.2M | ﹤0.01% |
555,811
+4,455
| +0.8% | +$34.7K |
|
|
AGTC
1490
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.16M | ﹤0.01% |
208,235
-155,622
| -43% | -$3.48M |
|
1491
Monolithic Power Systems
MPWR
$68.1B
| $4.13M | ﹤0.01% |
78,400
| – | – |
|
1492
Nektar Therapeutics
NKTR
$2.49B
| $4.12M | ﹤0.01% |
24,940
-3,454
| -12% | -$710K |
|
|
DWRE
1493
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $4.09M | ﹤0.01% |
67,116
+57,716
| +614% | +$3.36M |
|
1494
Starwood Property Trust
STWD
$6.05B
| $3.93M | ﹤0.01% |
161,600
-4,300
| -3% | -$103K |
|
1495
Ubiquiti
UI
$34.8B
| $3.87M | ﹤0.01% |
131,100
-6,500
| -5% | -$192K |
|
|
WPG
1496
DELISTED
Washington Prime Group Inc.
WPG
| $3.87M | ﹤0.01% |
25,840
+319
| +1% | +$49.4K |
|
1497
Liberty Media Series C
FWONK
$26.2B
| $3.81M | ﹤0.01% |
140,927
+2,838
| +2% | +$74.5K |
|
|
STAY
1498
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $3.75M | ﹤0.01% |
192,000
+12,800
| +7% | +$254K |
|
|
ETRM
1499
DELISTED
EnteroMedics Inc.
ETRM
| $3.71M | ﹤0.01% |
3,864
-36
| -0.9% | -$43.4K |
|
|
ATVI
1500
DELISTED
Activision Blizzard
ATVI
| $3.71M | ﹤0.01% |
163,259
+21,200
| +15% | +$464K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.